The potential seriousness of COVID-19 as a cause of harm and death has meant that the virus has impacted many aspects of medication use, processes and practices in hospitals, acre homes and in the community.
The New Zealand Pharmacovigilance Centre (NZPhvC) released a news item, published on the Te Tanu Hauora Health & Safety Commission’s website on 4th April 2024, welcoming insights and experiences on the theme of COVID-19 and medication safety. Website links in main article.